Insider trade

Teladoc Health (TDOC)Officer sold ~$45K

Adam C Vandervoort, Officer at Teladoc Health, sold ~$45K of Teladoc Health shares.

~$45K
Approx. value · 5,867 sh @ $7.59
75K
Holds after · shares reported
Traded
Sep 2, 2025
Filed
Sep 3, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 2, 2025 · this disclosureInsiderOfficer sold ~$45K of TDOC shares in the open market

What came next

  1. Sep 2, 2025Insider · 4 peopleInsiders: 4 sales (~$181K)
  2. Sep 3, 2025InsiderOfficer sold ~$31K of TDOC shares in the open market
  3. Sep 11, 2025InsiderCEO sold ~$127K of TDOC shares in the open market
  4. Oct 17, 2025Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results (and 1 more item)“On October 17, 2025, Ms. Mala Murthy, Chief Financial Officer of the Company, informed the Company of her decision to resign, effective November 21, 2025, to pursue another career opportunity outside of the healthcare industry.”
  5. Oct 29, 2025Company filing · Form 8-K · ResultsReported its results
  6. Dec 9, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 9, 2025, Teladoc Health, Inc. (the "Company" or "we") amended its 2023 Employment Inducement Incentive Award Plan (as amended, the “2023 Inducement Plan”) solely to increase the number of shares of common stock, par value $0.001 per share (“Common Stock”), reserved for issuance under the 2023 Inducement Plan by 1,780,000 shares, to a new total of 7,280,000 shares of Common Stock.”
  7. Dec 11, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 11, 2025, Mr. J. Eric Evans notified Teladoc Health, Inc. (the “Company”) of his intention not to stand for reelection at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”) and to retire from the Board effective as of the conclusion of the Annual Meeting.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Teladoc Health

For Teladoc Health, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TDOC page.

Other recent filings by Adam C Vandervoort, CHIEF LEGAL OFFICER, SECRETARY

The full history of Adam C Vandervoort, CHIEF LEGAL OFFICER, SECRETARY is on the profile page.

How this filing works

Other disclosures at Teladoc Health

Everything OQRO holds on this company is on its TDOC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data